Peijia Medical to Vote on Director Re-elections, Deloitte Appointment, and Capital Mandates at 29 May 2026 AGM

Bulletin Express
04/23

Peijia Medical Limited has circulated its proxy form for the Annual General Meeting scheduled for 9:30 a.m. on Friday, 29 May 2026, at No. 18 Yangjiatian Road, Suzhou Industrial Park, Jiangsu, China. Shareholders will decide on six ordinary resolutions that cover the company’s FY 2025 financial statements, board composition, auditor appointment, and share capital authorities.

Key items on the agenda include:

1. Financial Statements • Shareholders will consider and adopt the audited consolidated financial statements of Peijia Medical and its subsidiaries for the year ended 31 December 2025, together with the reports of the directors and auditor.

2. Board Composition and Remuneration • Re-election of four retiring directors: Executive Directors Dr. Yi Zhang and Ms. Hong Ye; Non-executive Director Mr. Jun Yang; and Independent Non-executive Director Dr. Stephen Newman Oesterle. • Authorisation for the board to determine directors’ remuneration.

3. Auditor Appointment • Appointment of Deloitte Touche Tohmatsu as the company’s auditor until the conclusion of the next AGM, with the board authorised to fix the auditor’s remuneration.

4. General Mandates on Share Capital • Authorise the board to allot, issue, and deal with additional shares— including the sale or transfer of any treasury shares—up to 20 % of the company’s issued share capital (excluding treasury shares) as at the date of approval. • Authorise the board to repurchase shares up to 10 % of issued share capital (excluding treasury shares). • Extend the share-issuance mandate by the amount of shares repurchased under the 10 % buy-back mandate.

Logistics and Voting • Shareholders may appoint one or more proxies; in the absence of a named proxy, the chairman of the meeting will act by default. • Completed proxy forms must reach Computershare Hong Kong Investor Services Limited by 9:30 a.m. on Wednesday, 27 May 2026 (Hong Kong time). • The proxy need not be a shareholder, and completion of the proxy form does not preclude shareholders from attending and voting in person.

The AGM decisions will shape Peijia Medical’s governance structure and provide the board with flexibility for future capital management during the next financial year.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10